Video Experimental Relacionado

Updated: Jan 7, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

1.0K

Más allá de los anticuerpos monoclonales: las limitaciones y el caso de los formatos alternativos de orientación

Natalia O Porozova1, Natalia V Petukhova2, Maxim A Gureev1

  • 1Laboratory of Bio- and Chemoinformatics, Faculty of Computer Science, Physics and Technology, National Research University Higher School of Economics, St. Petersburg, Russia.

Frontiers in immunology
|January 2, 2026
PubMed
Resumen

No abstract available in PubMed .

Palabras clave:
Ingeniería FcPD-1 y sus derivadosPD-L1 y sus derivadosanticuerpos bispecíficosreceptores de señueloEntrega por vía intratumoralandamios de anticuerpos de tamaño reducidomoléculas pequeñas

Más Videos Relacionados

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

1.7K
Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood06:07

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

6.1K

Videos de Conceptos Relacionados

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K